BiomX (NYSEAMERICAN:PHGE – Get Free Report) is anticipated to issue its quarterly earnings data before the market opens on Wednesday, April 2nd. Analysts expect the company to announce earnings of ($1.65) per share for the quarter.
BiomX Stock Up 1.7 %
Shares of PHGE opened at $0.57 on Monday. The stock has a market capitalization of $10.34 million, a price-to-earnings ratio of -0.18 and a beta of 1.27. BiomX has a one year low of $0.48 and a one year high of $4.99.
Wall Street Analyst Weigh In
Separately, HC Wainwright reissued a “buy” rating and set a $2.00 price objective on shares of BiomX in a research report on Wednesday, January 8th.
BiomX Company Profile
BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).
Further Reading
- Five stocks we like better than BiomX
- Investing In Automotive Stocks
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- MarketBeat Week in Review – 03/24 – 03/28
- How to Invest in Biotech Stocks
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.
